NCCN Guidelines® Insights: Breast Cancer, Version 4.2021
| Autor: | Joanne E. Mortimer, Mary Lou Smith, Rashmi Kumar, Karen L. Smith, Jame Abraham, Harold J. Burstein, Chau T. Dang, Doreen M. Agnese, Sharon H. Giordano, Lori J. Goldstein, Sara H. Javid, Sarah L. Blair, Jessica Young, Marilyn Leitch, Ingrid A. Mayer, Lori J. Pierce, Janice A. Lyons, Jairam Krishnamurthy, Kari B. Wisinski, John H. Ward, William J. Gradishar, Jennifer M. Matro, Matthew P. Goetz, Sameer A. Patel, Meena S. Moran, Erica Stringer-Reasor, Steven J. Isakoff, Ruth O'Regan, Jennifer L. Burns, Rebecca Aft, Hope S. Rugo, Melinda L. Telli, Anthony D. Elias, Rachel C. Jankowitz, Amy M. Sitapati, Kimberly H. Allison, Hatem Soliman, Sara A. Hurvitz |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty business.industry Carcinoma in situ Phyllodes tumor medicine.disease Inflammatory breast cancer Systemic therapy Patient advocacy 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Breast cancer Surgical oncology 030220 oncology & carcinogenesis Internal medicine Male breast cancer medicine skin and connective tissue diseases business |
| Zdroj: | Journal of the National Comprehensive Cancer Network. 19:484-493 |
| ISSN: | 1540-1413 1540-1405 |
| Popis: | The NCCN Guidelines for Breast Cancer include up-to-date guidelines for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, male breast cancer, and breast cancer during pregnancy. These guidelines are developed by a multidisciplinary panel of representatives from NCCN Member Institutions with breast cancer–focused expertise in the fields of medical oncology, surgical oncology, radiation oncology, pathology, reconstructive surgery, and patient advocacy. These NCCN Guidelines Insights focus on the most recent updates to recommendations for adjuvant systemic therapy in patients with nonmetastatic, early-stage, hormone receptor–positive, HER2-negative breast cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|